1. Home
  2. SUPN vs CHRN Comparison

SUPN vs CHRN Comparison

Compare SUPN & CHRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

N/A

Current Price

$29.57

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo ChronoScale Corporation Common Stock

CHRN

ChronoScale Corporation Common Stock

N/A

Current Price

$10.14

Market Cap

2.9B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SUPN
CHRN
Founded
2005
2026
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
2014
2012

Fundamental Metrics

Financial Performance
Metric
SUPN
CHRN
Price
$29.57
$10.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
★ $54.14
$28.50
AVG Volume (30 Days)
★ 2.4M
143.0K
Earning Date
10-29-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8100.00
92.67
EPS
★ 2.78
N/A
Revenue
★ $1,239,000,000.00
N/A
Revenue This Year
$51.56
$84.77
Revenue Next Year
$30.35
$603.10
P/E Ratio
$10.65
★ N/A
Revenue Growth
★ 4.29
N/A
52 Week Low
$25.92
$10.00
52 Week High
$59.68
$30.00

Technical Indicators

Market Signals
Indicator
SUPN
CHRN
Relative Strength Index (RSI) 31.65 34.16
Support Level $25.92 $10.00
Resistance Level $51.59 $22.29
Average True Range (ATR) 2.00 1.59
MACD -0.52 -0.19
Stochastic Oscillator 19.96 7.24

Price Performance

Historical Comparison
SUPN
CHRN

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About CHRN ChronoScale Corporation Common Stock

ChronoScale Holdings Corp is providing cloud services to customers at third-party colocation centers located in Colorado, Minnesota and Utah, such as artificial intelligence and machine learning developers, seeking to develop their products. It design, develop, and market exoskeleton and complementary products that augment human strength, endurance, and mobility. Its Cloud Business provides graphics processing unit (GPU) computing solutions that enable customers to execute critical workloads related to artificial intelligence (AI), machine learning (ML), rendering, and other High Performance Computing (HPC) tasks at scale in a capacity-constrained market. It has one operating segment Cloud Business.

Share on Social Networks: